CDN Renal Pharmacology for Dialysis Nurses

Question 1

Which erythropoiesis-stimulating agent (ESA) is most commonly used to treat anemia of chronic kidney disease in dialysis patients?

Accepted Answer

Epoetin alfa

Answer

Darbepoetin alfa

Answer

Romiplostim

Answer

Filgrastim

Question 2

What hemoglobin range is targeted when using ESA therapy in dialysis patients according to KDIGO guidelines?

Accepted Answer

10–11.5 g/dL

Answer

8–9 g/dL

Answer

12–13 g/dL

Answer

13–14 g/dL

Question 3

IV iron supplementation is indicated in dialysis patients when ferritin is below what threshold despite ESA therapy?

Accepted Answer

200 ng/mL

Answer

100 ng/mL

Answer

500 ng/mL

Answer

800 ng/mL

Question 4

Which phosphate binder is safe to use in dialysis patients with hypercalcemia?

Accepted Answer

Sevelamer hydrochloride

Answer

Calcium carbonate

Answer

Calcium acetate

Answer

All calcium-containing binders

Question 5

Cinacalcet (Sensipar) is used in dialysis patients primarily to treat which condition?

Accepted Answer

Secondary hyperparathyroidism with elevated PTH

Answer

Hyperkalemia

Answer

Anemia of chronic kidney disease

Answer

Dialysis-related amyloidosis

Question 6

Which antihypertensive class is preferred for dialysis patients with diabetic nephropathy to slow residual kidney disease progression?

Accepted Answer

ACE inhibitors or ARBs

Answer

Calcium channel blockers

Answer

Beta-blockers

Answer

Alpha-blockers